What is the treatment regimen for Arazlo (tazarotene) for acne?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 5, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Arazlo (Tazarotene) Treatment Regimen for Acne

Apply tazarotene cream 0.1% once daily in the evening as a thin layer (2 mg/cm²) to cover the entire affected area after gently cleansing and drying the face. 1

Application Instructions

  • Cleanse the face gently and ensure skin is completely dry before application 1
  • Apply a thin film (2 mg/cm²) once daily in the evening to all skin areas where acne lesions appear—use enough to cover the entire affected area, not just individual lesions 1
  • Wash hands thoroughly after application 1
  • Avoid contact with eyes, mouth, and mucous membranes; if contact occurs, rinse thoroughly with water 1

Timing Considerations for Optimal Use

  • If bathing or showering, ensure skin is completely dry before applying tazarotene 1
  • If using emollients or moisturizers, apply them at least one hour before tazarotene application 1
  • Evening application is required due to photosensitivity concerns 1

Mandatory Sun Protection

  • Use effective sunscreens daily and wear protective clothing during treatment, as tazarotene causes photosensitivity 1
  • Avoid exposure to sunlight, sunlamps, and weather extremes 1
  • Exercise caution if taking other photosensitizing medications concurrently 1

Managing Irritation and Tolerability

  • Common side effects include desquamation, dry skin, erythema, and burning sensation, occurring in 10-30% of patients 1
  • If excessive pruritus, burning, redness, or peeling occurs, either discontinue until skin integrity is restored or reduce dosing frequency to an interval the patient can tolerate 1
  • Alternative strategies to minimize irritation include short-contact therapy (30-60 minutes), combination with moisturizers, or application on alternate days 2, 3, 4
  • The cream formulation is better tolerated than gel formulations 5, 4

Combination Therapy Options

  • Tazarotene can be safely combined with benzoyl peroxide formulations or dapsone 5% gel to enhance efficacy 5
  • Combination with topical antibacterials is common practice for inflammatory acne 4
  • The American Academy of Dermatology recommends multimodal therapy combining topical retinoids with benzoyl peroxide as first-line treatment for acne 6

Critical Contraindications and Warnings

  • Tazarotene is absolutely contraindicated in pregnancy (Category X) and can cause severe fetal harm 2, 1
  • Females of childbearing potential must have a negative pregnancy test within 2 weeks prior to starting therapy and use effective contraception during treatment 1
  • Therapy should begin during a menstrual period 1
  • Safety and effectiveness have not been established in pediatric patients under 12 years of age 2

Expected Treatment Duration and Efficacy

  • Clinical trials typically evaluate efficacy at 12 weeks of treatment 7, 8
  • In one study, 53% of patients achieved remission by 12 weeks, with best results in grade 1 and grade 2 acne 8
  • Tazarotene 0.1% demonstrates greater comedolytic activity than tretinoin 0.025% gel or adapalene 0.1% gel 4

Common Pitfalls to Avoid

  • Do not apply to eczematous skin, as this may cause severe irritation 1
  • Avoid applying to unaffected skin, which is more susceptible to irritation 1
  • Do not use for ophthalmic, oral, or intravaginal purposes 1
  • Efficacy at reduced frequency of application has not been established, so dosing adjustments should be made cautiously 1

References

Guideline

Tazarotene Treatment Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Optimizing treatment with topical tazarotene.

American journal of clinical dermatology, 2003

Research

A status report on topical tazarotene in the management of acne vulgaris.

Journal of drugs in dermatology : JDD, 2013

Guideline

Acne Vulgaris Treatment Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.